lemborexant

CHEBI:CHEBI_751405

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
lemborexant
rxcui
2288427
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
route
ORAL
dosage_form
TABLET, FILM COATED
dea_schedule
CIV
active_ingredient_strength
10 mg/1
pharm_class_moa
Orexin Receptor Antagonists [MoA]
pharm_class
Orexin Receptor Antagonists [MoA]
nui
N0000190998
labeler_name
Eisai Manufacturing Ltd
manufacturer_name
Eisai Inc.
marketing_start_date
20200407
package_marketing_start_date
07-APR-20
pharm_class_epc
Orexin Receptor Antagonist [EPC]
product_ndc
60510-410
spl_id
fab80860-4be1-4a9b-a2f5-81a7d31f7d20
active_ingredient_name
LEMBOREXANT
package_ndc
60510-410-01
package_description
1 BAG in 1 DRUM (60510-410-01) / 1 TABLET, FILM COATED in 1 BAG
brand_name
DAYVIGO
brand_name_base
DAYVIGO
application_number
NDA212028
unii
0K5743G68X
spl_set_id
7074cb65-77b3-45d2-8e8d-da8dc0f70bfd
upc
0362856405904
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class